NasdaqGM - Nasdaq Real Time Price USD
Invivyd, Inc. (IVVD)
0.9571
+0.0271
+(2.91%)
As of 2:16:30 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 0.01 | 0.04 | 0.16 | 2.28 |
| Low Estimate | 0.01 | 0.04 | 0.16 | 2.28 |
| High Estimate | 0.01 | 0.04 | 0.16 | 2.28 |
| Year Ago EPS | -0.4 | -0.51 | -1.43 | 0.16 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | 23.16M | 29M | 110.78M | 289.24M |
| Low Estimate | 13.5M | 16.2M | 60.3M | 128.9M |
| High Estimate | 38.48M | 45.81M | 183.25M | 528.82M |
| Year Ago Sales | 2.26M | 9.3M | 25.38M | 110.78M |
| Sales Growth (year/est) | 923.01% | 211.88% | 336.44% | 161.08% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.39 | -0.35 | -0.1 | -0.01 |
| EPS Actual | -0.4 | -0.51 | -0.15 | -0.14 |
| Difference | -0.01 | -0.16 | -0.05 | -0.13 |
| Surprise % | -2.56% | -45.71% | -50.00% | -1,300.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.01 | 0.04 | 0.16 | 2.28 |
| 7 Days Ago | 0.01 | 0.04 | 0.16 | 2.28 |
| 30 Days Ago | 0.01 | 0.04 | 0.16 | 2.28 |
| 60 Days Ago | 0.05 | 0.03 | 0.13 | 1.63 |
| 90 Days Ago | 0.05 | 0.03 | 0.13 | 1.63 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IVVD | 102.50% | 107.84% | 111.19% | 1,325.00% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/28/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 5/16/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/26/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/20/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/5/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/24/2025 |
Related Tickers
AEON AEON Biopharma, Inc.
0.5808
+5.41%
XLO Xilio Therapeutics, Inc.
0.6749
-3.60%
SLXN Silexion Therapeutics Corp
0.9638
+0.40%
PSTV Plus Therapeutics, Inc.
0.3949
+7.50%
TNGX Tango Therapeutics, Inc.
3.2300
+27.17%
INAB IN8bio, Inc.
0.1241
-7.18%
IRD Opus Genetics, Inc.
1.0450
-4.15%
GNPX Genprex, Inc.
0.2934
-8.03%
BTAI BioXcel Therapeutics, Inc.
1.3800
+4.55%
INTS Intensity Therapeutics, Inc.
0.5063
-14.40%